Are Rare Variants Responsible for Susceptibility to Complex Diseases?
Open accessThe DOI matches its Crossref record; 41 of the 42 references it cites were found in a registry or an index.
Abstract
Little is known about the nature of genetic variation underlying complex diseases in humans. One popular view proposes that mapping efforts should focus on identification of susceptibility mutations that are relatively old and at high frequency. It is generally assumed-at least for modeling purposes-that selection against complex disease mutations is so weak that it can be ignored. In this article, I propose an explicit model for the evolution of complex disease loci, incorporating mutation, random genetic drift, and the possibility of purifying selection against susceptibility mutations. I show that, for the most plausible range of mutation rates, neutral susceptibility alleles are unlikely to be at intermediate frequencies and contribute little to the overall genetic variance for the disease. Instead, it seems likely that the bulk of genetic variance underlying diseases is due to loci where susceptibility mutations are mildly deleterious and where there is a high overall mutation rate to the susceptible class. At such loci, the total frequency of susceptibility mutations may be quite high, but there is likely to be extensive allelic heterogeneity at many of these loci. I discuss some practical implications of these results for gene mapping efforts.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Rare variants also contribute to disease risk14-17.”
From Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer's disease (2017) · cites this paper as [15]
In the citing paper
“These findings are consistent with the high levels of expression of both PLCG2 and ABI3 in peripheral monocytes, spleen, and whole blood reported by the ROADmap project and in microglia as reported by Zhang et al15.”
From Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer's disease (2017) · cites this paper as [15]
In the citing paper
“This suggests that these elevations are likely a consequence of changes in cell types that occur with AD, most likely microgliosis given that TREM2, PLCG2 and ABI3 are microglia-enriched genes15 (Supplementary Table 19, Supplementary Figure 12).”
From Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer's disease (2017) · cites this paper as [15]
In the citing paper
“Arguably a fundamental difficulty is that most of the mutations with large effects tend to be under strong negative selection, existing at very low frequencies in the population [22].”
From Integrated Model of De Novo and Inherited Genetic Variants Yields Greater Power to Identify Risk Genes (2013) · cites this paper as [22]
In the citing paper
“There are many reasons to believe that multiple rare variants, both within the same gene and across different genes, collectively influence the expression and prevalence of traits and diseases in the population at large.”
From Statistical analysis strategies for association studies involving rare variants (2010) · cites this paper as [15]
1 more claim about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Markov Chain Monte Carlo in Practice
(1995) · Chapman & Hall/CRC eBooks · doi:10.1201/b14835 · Cited by 7,757
The Future of Genetic Studies of Complex Human Diseases
Risch, N., & Merikangas, K. (1996) · Science · doi:10.1126/science.273.5281.1516 · Cited by 5,355 · cited 6×
“Under the " common disease, common variant " hypothesis, it may be possible to create a catalogue of common SNPs and to use association mapping to identify disease-susceptibility mutations from that list (Risch and Merikangas 1996; Cargill et al. 1999; Halushka et al. 1999).”
BackgroundResultInfluentialSpielman, R. S., McGinnis, R. E., & Ewens, W. J. (1993) · PubMed · Cited by 3,651
Searching for genetic determinants in the new millennium
Risch, N. J. (2000) · Nature · doi:10.1038/35015718 · Cited by 1,839 · cited 1×
“Mapping the genes that contribute to complex diseases—such as diabetes, schizophrenia, and hypertension—will be a major challenge of the postgenome era (Risch 2000).”
BackgroundGene genealogies and the coalescent process.
Hudson, R. R. (1990) · Medical Entomology and Zoology · Cited by 1,838
Mathematical Population Genetics
Baake, E., Ewens, W. J., & Wakolbinger, A. (2006) · Oberwolfach Reports · doi:10.4171/owr/2005/40 · Cited by 1,624
Characterization of single-nucleotide polymorphisms in coding regions of human genes
Cargill, M., Altshuler, D., Ireland, J., Sklar, P., Ardlie, K., Patil, N., Lane, C. R., Lim, E. P., Kalyanaraman, N., Nemesh, J., et al. (1999) · Nature Genetics · doi:10.1038/10290 · Cited by 1,547 · cited 1×
“One popular hypothesis proposes that the genetic factors underlying common diseases will be alleles that are themselves quite common in the population at large (Lander 1996; Chakravarti 1999).”
BackgroundOXFORD SURVEYS IN EVOLUTIONARY BIOLOGY
Allendorf, F. W. (1989) · Evolution · doi:10.1111/j.1558-5646.1989.tb02584.x · Cited by 1,449
Prospects for whole-genome linkage disequilibrium mapping of common disease genes
Kruglyak, L. (1999) · Nature Genetics · doi:10.1038/9642 · Cited by 1,416 · cited 5×
“Assumptions about the likely frequency spectrum of disease mutations are also critical in modeling linkage disequilibrium (Kruglyak 1999; Long and Langley 1999; Zöllner and von Haeseler 2000).”
BackgroundInfluentialLinkage strategies for genetically complex traits. I. Multilocus models.
RISCH, N. J. (1990) · PubMed · Cited by 1,309
Cited by
Items 801–900 of 1,000
Inherited Thrombophilia: Past, Present, and Future Research
Jorine, S., & Honkoop, P. (2011) · InTech eBooks · doi:10.5772/26050 · Cited by 7
“Opponents argued that in many complex diseases already a spectrum of disease associated rare variants had become known in direct contradiction of the CDCV hypothesis which states that only a few variants would account for the risk in complex diseases (Pritchard, 2001).”
BackgroundFang, S., Zhang, S., & Sha, Q. (2013) · Annals of Human Genetics · doi:10.1111/ahg.12038 · Cited by 7
“Studies of the genetic architecture of several diseases and simulation studies show that complex diseases are caused by both common and rare variants (Pritchard, 2001; Pritchard & Cox, 2002; Walsh & King, 2007; Stratton & Rahman, 2008; Bodmer & Bonilla, 2008; Ng et al., 2009; Teer & Mullikin, 2010).”
BackgroundDesign and Statistical Analysis of Pooled Next Generation Sequencing for Rare Variants
Wang, T., Lin, C., Zhang, Y., Wen, R., & Ye, K. Q. (2012) · Journal of Probability and Statistics · doi:10.1155/2012/524724 · Cited by 8
Genetic Epidemiology of Complex Phenotypes
Peddle, L., & Rahman, P. (2008) · Methods in molecular biology · doi:10.1007/978-1-59745-385-1_11 · Cited by 7
Genetic polymorphisms of vitamin D receptor (VDR) in Fabry disease
Teitcher, M., Weinerman, S., Whybra, C., Beck, M., Sharon, N. A., Elstein, D., & Altarescu, G. (2008) · Genetica · doi:10.1007/s10709-008-9245-y · Cited by 7
“, mild mutations, but where the mutations rate is high (Pritchard 2001).”
BackgroundPopulation Genomics of Drug Response
Halapi, E. C., Stefánsson, K., & Hakonarson, H. H. (2004) · American Journal of PharmacoGenomics · doi:10.2165/00129785-200404020-00002 · Cited by 7
Detecting epistasis via Markov bases
Malaspinas, A., & Uhler, C. (2011) · Journal of Algebraic Statistics · doi:10.18409/jas.v2i1.27 · Cited by 7
Translating Genomic Analyses into Improved Management of Coronary Artery Disease
Johansen, C. T., Lanktree, M. B., & Hegele, R. A. (2010) · Future Cardiology · doi:10.2217/fca.10.28 · Cited by 8
Evolutionary biology as a foundation for studying aging and aging-related disease
Ackermann, M., & Pletcher, S. D. (2007) · Oxford University Press eBooks · doi:10.1093/acprof:oso/9780199207466.003.0018 · Cited by 7
Wang, Y., Chen, Y.-H., & Yang, Q. (2012) · PLoS ONE · doi:10.1371/annotation/9a117865-2fb1-4356-a0ec-fda016d471a1 · Cited by 7
The Beginning of the End for the Epidemiologic Focus on Gene-Environment Interactions?
Sellers, T. A. (2006) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-06-0366 · Cited by 7
“Pritchard (9) has advocated consideration of rare alleles.”
BackgroundBlocking Approach for Identification of Rare Variants in Family-Based Association Studies
Turkmen, A., & Lin, S. (2014) · PLoS ONE · doi:10.1371/journal.pone.0086126 · Cited by 7
“Due to low allele frequencies, it is hypothesized that rare variants do not exhibit strong linkage disequilibrium (LD) with either rare or common SNVs [18,19].”
BackgroundPolymorphisms in CTNNBL1 in relation to colorectal cancer with evolutionary implications.
Huhn, S., Ingelfinger, D., Bermejo, J. L., Bevier, M., Pardini, B., Naccarati, A., Steinke, V., Rahner, N., Holinski‐Feder, E., Morak, M., et al. (2011) · PubMed · Cited by 6
Genetics of Inflammatory Bowel Diseases
Wei, Z., Baldassano, S. N., & Hakonarson, H. H. (2012) · Springer eBooks · doi:10.1007/978-1-4614-5061-0_1 · Cited by 7
Efficient Software for Multi-marker, Region-Based Analysis of GWAS Data
Sanjak, J. S., Long, A. D., & Thornton, K. (2016) · G3 Genes Genomes Genetics · doi:10.1534/g3.115.026013 · Cited by 6
“Speci fi cally, it arises from a model in which equilibrium allele frequencies and phenotypic effect sizes both re fl ect a balance between two things: recurrent unconditionally deleterious mutations occurring in a disease gene, and their elimination by natural selection (Pritchard 2001).”
EXOME SEQUENCING AND THE DIAGNOSTICS OF COMPLEX DISEASE PREDISPOSITION IN PREVENTIVE MEDICINE
Щербакова, Н. В., Meshkov, A. N., & Boytsov, S. A. (2013) · CARDIOVASCULAR THERAPY AND PREVENTION · doi:10.15829/1728-8800-2013-6-24-28 · Cited by 9
Ball, D., Pembrey, M. E., & Stephens, D. (2007) · Elsevier eBooks · doi:10.1016/b978-012370624-9/50007-4 · Cited by 6
Putting Genetics to Work in the Psychiatric Clinic
McMahon, F. J. (2022) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2021.22010024 · Cited by 6
Testing Rare Variants for Association with Diseases: A Bayesian Marker Selection Approach
Zhang, L., Pei, Y., Hai, R., Lin, Y., & Deng, H. (2011) · Annals of Human Genetics · doi:10.1111/j.1469-1809.2011.00684.x · Cited by 6
“…shown that multiple rare variants are as important as common variants in determining the aetiology of complex diseases and the variation of traits (Pritchard, 2001; Pritchard & Cox, 2002; Cohen et al., 2004; Cohen et al., 2006; Ahituv et al., ∗ Corresponding Authors: Yu-Fang Pei, Ph.D., Center of…”
Background[Autism, chromosome 15 and the GAbaergic dysfunction hypothesis].
Solís-Áñez, E., Delgado-Luengo, W., & Hernández, M. L. (2007) · PubMed · Cited by 20
Liu, Y., Huang, C. H., Hu, I., Lo, S., & Zheng, T. (2011) · BMC Proceedings · doi:10.1186/1753-6561-5-s9-s106 · Cited by 6
“Background Rare variants are common on the genome and have long been speculated to be involved in the etiology of most human disorders [1].”
BackgroundA powerful association test of multiple genetic variants using a random-effects model
Cheng, K. F., Lee, J. Y., Zheng, W., & Li, C. (2013) · Statistics in Medicine · doi:10.1002/sim.6068 · Cited by 6
Detecting the dominance component of heritability in isolated and outbred human populations
Herzig, A. F., Nutile, T., Ruggiero, D., Ciullo, M., Perdry, H., & Leutenegger, A. (2018) · Scientific Reports · doi:10.1038/s41598-018-36050-7 · Cited by 6
Catania, F., Rothering, R., & Vitali, V. (2021) · Genome Biology and Evolution · doi:10.1093/gbe/evab263 · Cited by 6
Role of pharmacogenomics in drug development
Hakonarson, H. H., & Stefánsson, K. (2004) · Drug Development Research · doi:10.1002/ddr.10367 · Cited by 6
“…the relevance of several of the disease genes that have been uncovered using this approach has been established in a diversity of populations, including both populations from Central Europe, North America, and Asia [Hastbacka et al., 1992; Kerem et al., 1989; Pritchard, 2001; Jorde et al., 1993].”
BackgroundTarget identification and validation through genetics
Allen, M., & Carey, A. H. (2004) · Drug Discovery Today TARGETS · doi:10.1016/s1741-8372(04)02450-8 · Cited by 6
Approaches to determine clinical significance of genetic variants
MacAuley, A., & Ladiges, W. (2005) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/j.mrfmmm.2005.01.009 · Cited by 6
Whole genome variation analysis using single molecule sequencing
Smith, T. J. (2004) · Drug Discovery Today TARGETS · doi:10.1016/s1741-8372(04)02423-5 · Cited by 6
Generalization of Rare Variant Association Tests for Longitudinal Family Studies
Chien, L., Hsu, F., Bowden, D. W., & Chiu, Y. (2016) · Genetic Epidemiology · doi:10.1002/gepi.21951 · Cited by 7
“LDs among rare variants tend to be small, so we first simulated independent genetic variants [Pritchard, 2001; Turkmen and Lin, 2014].”
BackgroundA Short Primer on the Functional Analysis of Copy Number Variation for Biomedical Scientists
Barnes, M. R., & Breen, G. D. (2010) · Methods in molecular biology · doi:10.1007/978-1-60327-367-1_7 · Cited by 6
The evolutionary context of human aging and degenerative disease
Austad, S. N., & Finch, C. E. (2007) · Oxford University Press eBooks · doi:10.1093/acprof:oso/9780199207466.003.0023 · Cited by 6
Study design in mapping complex disease traits
Campbell, H. J., & Rudan, I. (2007) · Cambridge University Press eBooks · doi:10.1017/cbo9780511543555.007 · Cited by 6
Genome-Wide Association Studies
Al‐Chalabi, A. (2009) · Cold Spring Harbor Protocols · doi:10.1101/pdb.top66 · Cited by 7
A variance component-based gene burden test
Peralta, J. M., Almeida, M., Kent, J. W., & Blangero, J. (2014) · BMC Proceedings · doi:10.1186/1753-6561-8-s1-s49 · Cited by 5
“Background Complex phenotypes are thought to be determined by the aggregate effects of many rare causal variations [1-3].”
BackgroundLavanchy, E., Cumer, T., Topaloudis, A., Ducrest, A., Simon, C., Roulin, A., & Goudet, J. (2024) · Heredity · doi:10.1038/s41437-024-00728-8 · Cited by 6
The Abundance of Harmful Rare Homozygous Variants in Children of Consanguineous Parents
Subramanian, S. (2025) · Biology · doi:10.3390/biology14030310 · Cited by 5
“Some investigators argue that rare variants also could cause common diseases [40].”
Leveraging low-cost short-read sequencing: revolutionizing complex trait genetics
Ruckman, S. N., & Long, A. D. (2026) · Molecular Biology and Evolution · doi:10.1093/molbev/msag025 · Cited by 5
“Still, despite their high power and theoretical resolution, GWAS are best suited for detecting intermediate frequency loci (Pritchard 2001; Spencer et al. 2009) and have struggled to identify causative mutations (Zuk et al. 2012; Visscher et al. 2017).”
Optimal Estimation of the Null Distribution in Large-Scale Inference
Kotekal, S., & Gao, C. (2025) · IEEE Transactions on Information Theory · doi:10.1109/tit.2025.3529457 · Cited by 11
“One proposed explanation to this “missing heritability problem” [38], [39] is that complex traits involve many, many genetic variants which individually may not have large effect sizes (and thus go undetected) but collectively have large influence [34], [35], [40], [41], [42].”
Genetics of Psychiatric Disorders: Advances in Genetic Epidemiology and Molecular Genetics
Merikangas, K. R., & Karayiorgou, M. (2015) · Wiley eBooks · doi:10.1002/9781118753378.ch16 · Cited by 5
Adaptive Combination of P-Values for Family-Based Association Testing with Sequence Data
Lin, W. (2014) · PLoS ONE · doi:10.1371/journal.pone.0115971 · Cited by 6
Oppong, R., Boutin, T., Campbell, A., McIntosh, A. M., Porteous, D. J., Hayward, C., Haley, C., Navarro, P., & Knott, S. (2022) · Frontiers in Genetics · doi:10.3389/fgene.2021.791712 · Cited by 6
“Moreover, some of these true causal variants may be rare (Pritchard, 2001) and therefore may be in incomplete linkage disequilibrium (LD) with genotyped SNPs (Yang et al.”
BackgroundGenome-Wide Association Studies and Human Population Obesity
Loos, R. J. F., & Kilpeläinen, T. O. (2010) · Endocrine updates · doi:10.1007/978-1-4419-7034-3_5 · Cited by 5
Current and Future Directions in Genomics of Amyotrophic Lateral Sclerosis
Ravits, J., & Traynor, B. J. (2008) · Physical Medicine and Rehabilitation Clinics of North America · doi:10.1016/j.pmr.2008.04.001 · Cited by 5
Zhang, G. (2015) · Current Genetic Medicine Reports · doi:10.1007/s40142-015-0083-9 · Cited by 7
“The CDRV model has a logical evolutionary explanation—variants that increase disease risk should be under purifying selection which prevents them from drifting to a higher frequency in the population [24].”
BackgroundReconstructing recent population history while mapping rare variants using haplotypes
Yunusbaev, U., Valeev, A., Yunusbaeva, M. M., Kwon, H. W., Mägi, R., Metspalu, M., & Yunusbayev, B. (2019) · Scientific Reports · doi:10.1038/s41598-019-42385-6 · Cited by 6
The genetic contribution to epilepsy: the known and missing heritability
Johnson, M. R. (2011) · Cambridge University Press eBooks · doi:10.1017/cbo9780511921001.008 · Cited by 5
Vasseur, F. (2003) · International Congress Series · doi:10.1016/s0531-5131(03)00137-7 · Cited by 7
Jones, H. B., & Faham, M. (2005) · Human Heredity · doi:10.1159/000086118 · Cited by 6
“Some other theoretical work suggested the disease alleles are likely to be common while others propose that rare and heterogeneous variants are important [Pritchard, 2001; Reich and Lander, 2001].”
BackgroundImproved Detection of Rare Genetic Variants for Diseases
Zhang, L., Pei, Y., Li, J., Papasian, C. J., & Deng, H. (2010) · PLoS ONE · doi:10.1371/journal.pone.0013857 · Cited by 6
“Therefore, it is reasonable to propose that there are limitations to the CDCV hypothesis, and to consider the alternative common disease-rare variants (CDRV) hypothesis as a complement [5,6,7,8].”
BackgroundCancer: evolutionary origins of vulnerability
Greaves, M. F. (2007) · Oxford University Press eBooks · doi:10.1093/acprof:oso/9780199207466.003.0021 · Cited by 7
Search for genetic variants influencing human height
Sammalisto, S. (2008) · Helda - University of Helsinki Institutional Repository · Cited by 8
ATM , ATR and Mre11 complex genes in hereditary susceptibility to breast cancer
Pylkäs, K. (2007) · Cited by 5
Pharmacogenetics in Cancer Chemotherapy
Wu, X., & Gu, J. H. (2008) · CRC Press eBooks · doi:10.3109/9781420052923-10 · Cited by 5
Familial Studies: Genetic Inferences
Diego, V. P., Kent, J. W., & Blangero, J. (2015) · Elsevier eBooks · doi:10.1016/b978-0-08-097086-8.82029-2 · Cited by 5
Detecting association of rare and common variants by adaptive combination of P-values
Zhou, Y.-J., & Wang, Y. (2015) · Genetics Research · doi:10.1017/s0016672315000208 · Cited by 4
“It has been hypothesized that some of the heritabilitymaybe explained byunidentified rare variants (Pritchard, 2001; Pritchard & Cox, 2002; Manolio et al., 2009).”
BackgroundChapel, M., Dennis, J. K., & de Boer, C. G. (2026) · Cell Genomics · doi:10.1016/j.xgen.2025.101131 · Cited by 4
Autism and Schizophrenia Are Disorders of Evolvability
Gualtieri, C. T. (2014) · Open Journal of Medical Psychology · doi:10.4236/ojmp.2014.32019 · Cited by 4
“Yet, novel mutations occur all the time [214-218].”
BackgroundLarson, N. B., McDonnell, S. K., Cannon‐Albright, L., Teerlink, C. C., Stanford, J. L., Ostrander, E. A., Isaacs, W. B., Xu, J., Cooney, K. A., Lange, E. M., et al. (2016) · Genetic Epidemiology · doi:10.1002/gepi.21983 · Cited by 4
Guan, Z., Shen, R., & Begg, C. B. (2021) · Human Heredity · doi:10.1159/000519355 · Cited by 4
Jin, S. C., Benítez, B. A., Deming, Y. K., & Cruchaga, C. (2015) · Methods in molecular biology · doi:10.1007/978-1-4939-2627-5_18 · Cited by 4
A concise history of genome-wide association studies
Al‐Ali, A. K., Koeleman, B. P. C., van der Laan, S. W., & Asselbergs, F. W. (2013) · Saudi Journal of Medicine and Medical Sciences · doi:10.4103/1658-631x.112902 · Cited by 5
Wang, T., Zhou, B., Guo, T., Bidlingmaier, M., Wallaschofski, H., Teumer, A., Vasan, R. S., & Kaplan, R. C. (2013) · Genetic Epidemiology · doi:10.1002/gepi.21766 · Cited by 4
“E-mail: tao.wang@einstein.yu.edu Pritchard, 2001].”
Agne, M., Huang, C., Hu, I., Wang, M. H., Zheng, T., & Lo, S. (2014) · BMC Proceedings · doi:10.1186/1753-6561-8-s1-s7 · Cited by 4
“The possible influence of rare variants on disease susceptibility has garnered more attention in recent years [2,3].”
BackgroundTayo, B. O., Tong, L., & Cooper, R. (2016) · BMC Proceedings · doi:10.1186/s12919-016-0054-5 · Cited by 4
RARE: evolutionary feature engineering for rare-variant bin discovery
Dasariraju, S., & Urbanowicz, R. J. (2021) · Genetic and Evolutionary Computation Conference Companion (GECCO Companion) · doi:10.1145/3449726.3463174 · Cited by 4
“For example, despite genome-wide association studies (GWAS) elucidating the role of ‘common’ genetic variants in disease associations [26, 28], uncertainty surrounding the contribution of rare genetic variation in complex diseases persists [13, 38].”
Genetic Epidemiology of Complex Phenotypes
O’Rielly, D. D., & Rahman, P. (2021) · Methods in molecular biology · doi:10.1007/978-1-0716-1138-8_19 · Cited by 5
Neuroendocrine Regulation of Puberty
Terasawa, E., & Ojeda, S. R. (2009) · Elsevier eBooks · doi:10.1016/b978-008088783-8.00064-4 · Cited by 7
Experimental Approaches for Identifying Schizophrenia Risk Genes
Mantripragada, K. K., Carroll, L. S., & Williams, N. M. (2010) · Current topics in behavioral neurosciences · doi:10.1007/7854_2010_58 · Cited by 6
Characterizing the Extent of Human Genetic Variation for Performance‐Related Traits
Blangero, J., & Kent, J. W. (2010) · Wiley eBooks · doi:10.1002/9781444327335.ch3 · Cited by 4
Severe asthma and allergy: mechanisms, diagnostics and treatment
Hedlin, G., & van Hage, M. (2012) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2012.02557.x · Cited by 4
The Genetic Basis of Bipolar Disorder
Hou, L., & McMahon, F. J. (2016) · Milestones in drug therapy · doi:10.1007/978-3-319-31689-5_5 · Cited by 4
Functional Genomics and Its Implications for Molecular Medicine
Broeckel, U., Maresso, K. C., & Kugathasan, S. (2006) · Pediatric Clinics of North America · doi:10.1016/j.pcl.2006.08.007 · Cited by 4
Boussioutas, A., & Haviv, I. (2003) · Tissue Antigens · doi:10.1034/j.1399-0039.2003.00109.x · Cited by 4
Computational analysis of human genome polymorphism
Ramensky, V. E., & Sunyaev, S. R. (2009) · Molecular Biology · doi:10.1134/s0026893309020095 · Cited by 4
“Recent studies yielded potent evidence for the alternative common disease–rare variant (CD–RV) hypothesis, which suggests that the majority of complex phenotypes, in particular, susceptibility to diseases, are determined by an excess of potentially adverse rare alleles of genes that are involved in metabolic and signa…”
BackgroundMorris, B. J., Lin, R. C. Y., Wang, X. L., Dalziel, B., & Caterson, I. D. (2003) · Obesity Research · doi:10.1038/oby.2003.214 · Cited by 6
Prioritizing Rare Variants with Conditional Likelihood Ratios
Li, W., Dobbins, S. E., Tomlinson, I. P. M., Houlston, R. S., Pal, D. K., & Strug, L. J. (2015) · Human Heredity · doi:10.1159/000371579 · Cited by 4
“Due to the low MAF, rare variants usually do not show strong linkage disequilibrium with each other [23, 24], and therefore, all variants were simulated independently of each other.”
Survival of the Curviest: Noise-Driven Selection for Synergistic Epistasis
Wilkins, J. F., McHale, P. T., Gervin, J., & Lander, A. D. (2016) · PLoS Genetics · doi:10.1371/journal.pgen.1006003 · Cited by 4
Association Mapping and Disease: Evolutionary Perspectives
Besenbacher, S., Mailund, T., & Schierup, M. H. (2012) · Methods in molecular biology · doi:10.1007/978-1-61779-585-5_11 · Cited by 4
“Manolio TA, Collins FS, Cox NJ, Goldstein DB (2009) Finding the missing heritability of complex diseases.”
BackgroundInfluentialTong, X., Wei, C., & Lu, Q. L. (2016) · BMC Proceedings · doi:10.1186/s12919-016-0017-x · Cited by 4
“Driven by the advance of sequencing technology and limited heritability explained by the genome-wide association studies (GWAS) findings [2, 3], current research focus has shifted toward studying rare variants associated with common complex diseases.”
BackgroundIdiopathic epilepsy of childhood and potassium ion channels.
Dai, A. I., & Wasay, M. (2007) · PubMed · Cited by 4
The loss of statistical power to distinguish populations when certain samples are ambiguous
O’Hely, M., & Slatkin, M. (2003) · Theoretical Population Biology · doi:10.1016/s0040-5809(03)00084-4 · Cited by 4
“…C does carry some information on the causative locus, it does not add to that which is carried by B: Whether causative alleles tend to be rare or common is a question that, in the absence of adequate data, can be debated only on theoretical grounds (e.g. Pritchard, 2001; Reich and Lander, 2001).”
BackgroundStatistical Methods for studying Genetic Variation in Populations
Shringarpure, S. (2012) · KiltHub Repository · doi:10.1184/r1/6723164 · Cited by 5
Hemmings, S. M. J. (2006) · SUNScholar (Stellenbosch University) · Cited by 6
Genetic background of claw health in dairy cattle
van der Spek, D. (2015) · doi:10.18174/354190 · Cited by 4
Hartman, K., Rashkin, S. R., Witte, J. S., & Hernandez, R. D. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2019.12.18.879916 · Cited by 4
“If alleles that have major causal effects on a phenotype are evolutionarily deleterious, then natural selection will preferentially keep large effect alleles at low frequency, and this process can indeed drive rare variants to constitute a substantial fraction of heritability (Pritchard, 2001; Eyre-Walker, 2010; Simon…”
BackgroundMultistage Genetic Association Studies
Thomas, D. C., & Conti, D. V. (2007) · Wiley eBooks · doi:10.1002/9780471462422.eoct315 · Cited by 4
Challenges for the 21st Century
(2001) · Nature Genetics · doi:10.1038/ng1201-353 · Cited by 4
Hamazaki, K., Iwata, H., & Mary‐Huard, T. (2025) · Genetics · doi:10.1093/genetics/iyaf038 · Cited by 3
Collapsing singletons may boost signal for associating rare variants in sequencing study
Wang, W., & Wei, Z. (2014) · BMC Proceedings · doi:10.1186/1753-6561-8-s1-s50 · Cited by 3
“1% and 1%, may be functionally relevant and causal for a larger proportion of inheritable variability [2,3].”
BackgroundJohnson, T. A., Niimura, Y., Tanaka, H., Nakamura, Y., & Tsunoda, T. (2011) · Genome biology · doi:10.1186/gb-2011-12-3-r21 · Cited by 3
“The predominant model for such studies has been the common disease/common variant hypothesis [61], but other hypotheses have been proposed, such as the multiple rare variant hypothesis [18,62].”
BackgroundPoisson Approximation–Based Score Test for Detecting Association of Rare Variants
Fang, H., Zhang, H., & Yang, Y. (2016) · Annals of Human Genetics · doi:10.1111/ahg.12154 · Cited by 3
“We adopted the additive model that was nearly equivalent to the dominant model when MAF was small enough, and the variants were independent since the correlations between rare variants were usually very low (Pritchard, 2001; Pritchard & Cox, 2002).”
BackgroundMethodGenetic Association Study Design
Zondervan, K. T. (2010) · Elsevier eBooks · doi:10.1016/b978-0-12-375142-3.10003-3 · Cited by 4
Rytova, A. I., Khlebus, E., Шевцов, А. Е., Kutsenko, V. A., Щербакова, Н. В., Zharikova, A. A., Ershova, A. I., Kiseleva, A. V., Boytsov, S. A., Yarovaya, E. B., et al. (2017) · Russian Journal of Genetics · doi:10.1134/s1022795417100088 · Cited by 3
Andersen, M. K., Grarup, N., Moltke, I., Albrechtsen, A., & Hansen, T. F. (2018) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2018.02.010 · Cited by 3
Dai, A. I., Bay, A., Gorucu, S., Sivaslı, E., & Boşnak, M. (2011) · Neurology Psychiatry and Brain Research · doi:10.1016/j.npbr.2011.02.008 · Cited by 3
Testing for Modes of Inheritance Involving Compound Heterozygotes
Bacanu, S. (2013) · Genetic Epidemiology · doi:10.1002/gepi.21732 · Cited by 3
“…– p )βn–1eσ(1–p ) (where p is the mutation allele frequency), ln(βs) is assumed to be uniform between ln(0.1) and ln(3), ln(βn) uniform between ln(0.001) and ln(0.01), and σ is assumed to be 0 with probability 0.5 and distributed as a uniform between 0 and 20 with probability 0.5 [Pritchard, 2001].”
BackgroundInfluentialThe Impact of GWAS Findings on Cancer Etiology and Prevention
Figueiredo, J. C., Stram, D. O., & Haiman, C. A. (2014) · Current Epidemiology Reports · doi:10.1007/s40471-014-0017-1 · Cited by 3
Rare variants analysis by risk-based variable-threshold method
Fang, H., Hou, B., Wang, Q., & Yang, Y. (2013) · Computational Biology and Chemistry · doi:10.1016/j.compbiolchem.2013.04.001 · Cited by 3
The genome as pharmacopeia: Association of genetic dose with phenotypic response
Wadhawan, S., Runz, H., & Burchard, J. (2015) · Biochemical Pharmacology · doi:10.1016/j.bcp.2015.02.005 · Cited by 3
A statistical method for scanning the genome for regions with rare disease alleles
Garner, C. P. (2010) · Genetic Epidemiology · doi:10.1002/gepi.20483 · Cited by 3
“Theory predicts that weak natural selection against the disease alleles in a disease susceptibility region would increase the number of disease alleles [Pritchard, 2001; Pritchard and Cox, 2002], thereby increasing the power of the proposed method to detect the region.”
Background
Metadata
- Authors
- Pritchard, J. K.
- Affiliations
- University of Oxford (GB)
- Corresponding author
- Pritchard, Jonathan K.
- Venue
- The American Journal of Human Genetics
- Publisher
- Elsevier BV
- Published
- 2001-07
- Volume
- 69
- Issue
- 1
- Pages
- 124-137
- ISSN
- 0002-9297 (ISSN-L)
- PMC
- PMC1226027
- OpenAlex
- W2129559300
- Cited by
- 1,197
- References
- 42
- Citations by year
- 2026: 9 · 2025: 11 · 2024: 15 · 2023: 8 · 2022: 17 · 2021: 18 · 2020: 11 · 2019: 39 · 2018: 41 · 2017: 40 · 2016: 50 · 2015: 58 · 2014: 68 · 2013: 69 · 2012: 78
- FWCI
- 30.48
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/open-access/userlicense/1.0/ (vor, 4401 d)
- Locations
- The American Journal of Human Genetics (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Burroughs Wellcome Fund
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Evolution and Genetic Dynamics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genomics and Rare Diseases
- Keywords
- complex diseases, rare variants, purifying selection, genetic drift, mutation rate, genetic variance, allelic heterogeneity, gene mapping, deleterious mutations
- MeSH terms
- Alleles, Chromosome Mapping, Computer Simulation, Female, Gene Frequency, Humans, Genetic Linkage, Male, Models, Genetic, Mutation, Pedigree, Phenotype, Polymorphism, Genetic, Probability, Selection, Genetic, Software, Genetic Variation, Mutagenesis, Genetic Heterogeneity, Genetic Predisposition to Disease, Genetic Diseases, Inborn
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.